Crescent Biopharma (CBIO) Revenue (2013 - 2026)
Crescent Biopharma (CBIO) revenue from Mar 31, 2013 to Mar 31, 2026. The TTM Crescent Biopharma (CBIO) revenue is $1.04M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Crescent Biopharma (CBIO) Revenue CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | +135.13% |
| 5 Years TTM | -14.07% |
| 10 Years TTM | -25.62% |
| All Time TTM | +15.22% |
Annual Revenue change of Crescent Biopharma (CBIO)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $1.04M | -90.41% |
| 2025 | $11M | N/A |
| 2024 | $0 | -100.00% |
| 2023 | $10K | -87.50% |
| 2022 | $80K | -93.10% |
| 2021 | $1.16M | -88.58% |
| 2020 | $10M | N/A |
| 2019 | $0 | N/A |
| 2018 | $0 | N/A |
| 2017 | $0 | -100.00% |
| 2016 | $20K | -99.90% |
| 2015 | $20M | +33.53% |
| 2014 | $15M | +276.69% |
| 2013 | $3.99M | -73.85% |
| 2012 | $15M | N/A |
Comparison Crescent Biopharma (CBIO) five years revenue CAGR with competitors
Crescent Biopharma (CBIO) five years revenue CAGR is -14.08%.